{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:15:16Z","timestamp":1783178116463,"version":"3.54.6"},"reference-count":40,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2013,3,13]]},"published-print":{"date-parts":[[2013,7]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To ascertain the hypothesis that the phenotypic differences between Bickerstaff's brainstem encephalitis (BBE) and Miller Fisher syndrome (MFS) are derived from the differences in the effects of sera on blood\u2013brain barrier (BBB) and blood\u2013nerve barrier.<\/jats:p><\/jats:sec><jats:sec><jats:title>Background<\/jats:title><jats:p>Antibodies against GQ1b are frequently detected in BBE and MFS, and these two disorders may share the same pathogenesis, but the clinical phenotypes of BBE and MFS are substantially different.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The effects of sera obtained from BBE patients, MFS patients and control subjects were evaluated with regard to the expression of tight junction proteins and transendothelial electrical resistance in human brain microvascular endothelial cells (BMECs) and human peripheral nerve microvascular endothelial cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The sera obtained from BBE patients decreased the transendothelial electrical resistance values and claudin-5 protein expression in BMECs, although the sera obtained from MFS patients had no effect on BMECs or peripheral nerve microvascular endothelial cells. This effect was reversed after the application of matrix metalloproteinase (MMP) inhibitor, GM6001. The presence or absence of anti-GQ1b antibodies did not significantly influence the results. MMP-9 secreted by BMECs was significantly increased after exposure to the sera obtained from BBE patients, whereas it was not changed after exposure to the sera obtained from MFS patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Only the sera obtained from BBE patients destroyed BBB and it might explain the phenotypical differences between BBE and MFS. BBE sera disrupted BBB, possibly via the autocrine secretion of MMP-9 from BBB-composing endothelial cells.<\/jats:p><\/jats:sec>","DOI":"10.1136\/jnnp-2012-304306","type":"journal-article","created":{"date-parts":[[2013,4,13]],"date-time":"2013-04-13T01:09:46Z","timestamp":1365815386000},"page":"756-765","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":39,"title":["Blood\u2013brain barrier destruction determines Fisher\/Bickerstaff clinical phenotypes: an in vitro study"],"prefix":"10.1136","volume":"84","author":[{"given":"Kazuyuki","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitaka","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiaki","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuteru","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Tasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyo","family":"Haruki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Kusunoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehiro","family":"Mizusawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2013,4,12]]},"reference":[{"key":"2024031110301381000_84.7.756.1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.4723.77"},{"key":"2024031110301381000_84.7.756.2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5032.1384"},{"key":"2024031110301381000_84.7.756.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM195607122550201"},{"key":"2024031110301381000_84.7.756.4","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-008-0775-0"},{"key":"2024031110301381000_84.7.756.5","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410310619"},{"key":"2024031110301381000_84.7.756.6","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(93)90250-3"},{"key":"2024031110301381000_84.7.756.7","doi-asserted-by":"publisher","DOI":"10.1159\/000070630"},{"key":"2024031110301381000_84.7.756.8","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-302312"},{"key":"2024031110301381000_84.7.756.9","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-303060"},{"key":"2024031110301381000_84.7.756.10","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awg233"},{"key":"2024031110301381000_84.7.756.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67665-9"},{"key":"2024031110301381000_84.7.756.12","first-page":"265","article-title":"Microenvironment of the peripheral nervous system under normal and pathological conditions","volume":"5","author":"Olsson","year":"1990","journal-title":"Crit Rev Neurobiol"},{"key":"2024031110301381000_84.7.756.13","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.22232"},{"key":"2024031110301381000_84.7.756.14","doi-asserted-by":"publisher","DOI":"10.1247\/csf.11042"},{"key":"2024031110301381000_84.7.756.15","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2011-300434"},{"key":"2024031110301381000_84.7.756.16","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20778"},{"key":"2024031110301381000_84.7.756.17","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod.107.063743"},{"key":"2024031110301381000_84.7.756.18","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.3748\/wjg.v12.i26.4241","article-title":"Expression of angiopoietins, Tie 2 and vascular endothelial growth factor in angiogenesis and progression of hepatocellular carcinoma","volume":"12","author":"Zhang","year":"2006","journal-title":"World J Gastroenterol"},{"key":"2024031110301381000_84.7.756.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2009.06362.x"},{"key":"2024031110301381000_84.7.756.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2010.05.096"},{"key":"2024031110301381000_84.7.756.21","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.22514"},{"key":"2024031110301381000_84.7.756.22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/jcp.22337","article-title":"Peripheral nerve pericytes modify the blood\u2013nerve barrier function and tight junctional molecules through the secretion of various soluble factors","volume":"226","author":"Shimizu","year":"2010","journal-title":"J Cell Physiol"},{"key":"2024031110301381000_84.7.756.23","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200302070"},{"key":"2024031110301381000_84.7.756.24","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1212\/WNL.55.4.585","article-title":"Anti-GM1 antibody fascilitates leakage in an in vitro blood\u2013nerve barrier model","volume":"55","author":"Kanda","year":"2000","journal-title":"Neurology"},{"key":"2024031110301381000_84.7.756.25","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.126.1.235"},{"key":"2024031110301381000_84.7.756.26","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199908)22:8<1071::AID-MUS10>3.0.CO;2-0"},{"key":"2024031110301381000_84.7.756.27","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.10.1911"},{"key":"2024031110301381000_84.7.756.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(96)01123-7"},{"key":"2024031110301381000_84.7.756.29","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.08-3333"},{"key":"2024031110301381000_84.7.756.30","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-002-0604-1"},{"key":"2024031110301381000_84.7.756.31","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/121.1.159"},{"key":"2024031110301381000_84.7.756.32","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410430404"},{"key":"2024031110301381000_84.7.756.33","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1212\/WNL.53.8.1683","article-title":"Matrix metalloproteinase-9 is increased and correlates with severity in Guillain-Barr\u00e9 syndrome","volume":"53","author":"Cr\u00e9ange","year":"1999","journal-title":"Neurology"},{"key":"2024031110301381000_84.7.756.34","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1523\/JNEUROSCI.21-19-07724.2001","article-title":"Effects of Matrix metalloproteinase-9 Gene knock-out on the proteolysis of Blood\u2013Brain Barrier and White matter Components after cerebral Ischemia","volume":"21","author":"Asahi","year":"2001","journal-title":"J Neurosci"},{"key":"2024031110301381000_84.7.756.35","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-200109170-00050"},{"key":"2024031110301381000_84.7.756.36","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117578"},{"key":"2024031110301381000_84.7.756.37","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/120.10.1895"},{"key":"2024031110301381000_84.7.756.38","unstructured":"Corkill DJ Woolley K Guard S . The effect of a novel inhibitor of tumour necrosis factor-\u03b1 processing, BB-1101, in experimental autoimmune encephalomyelitis. Br J Pharmacol 1995;(Suppl 116):8P."},{"key":"2024031110301381000_84.7.756.39","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410330606"},{"key":"2024031110301381000_84.7.756.40","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1212\/WNL.56.6.758","article-title":"Preceding infections, immune factors, and outcome in Guillain-Barr\u00e9 syndrome","volume":"56","author":"Hadden","year":"2001","journal-title":"Neurolgy"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2012-304306","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T17:30:33Z","timestamp":1710178233000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2012-304306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,12]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,6,9]]},"published-print":{"date-parts":[[2013,7]]}},"alternative-id":["10.1136\/jnnp-2012-304306"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2012-304306","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,12]]}}}